A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2006
11/15/2006	CN1863554A Process for preparing polysaccharide-protein conjugate vaccines
11/15/2006	CN1863553A Process for preparing polysaccharide-protein conjugate vaccines
11/15/2006	CN1863552A Tyrosinase mutant and methods of use thereof
11/15/2006	CN1863546A Methods for treating cardiovascular disease using a soluble ctla4 molecule
11/15/2006	CN1861793A Coding hemaagglutinin gene of poultry influenza virus, plant expressing carrier and application thereof
11/15/2006	CN1861792A Coding of thermal sensitive toxin gene of bacillus coli, expressing carrier and application thereof
11/15/2006	CN1861195A Fowl vaccine immunopotentiator of chicken interleuken-18, and its application
11/15/2006	CN1284859C Membrane virus host range mutations and their uses as vaccine substrates
11/15/2006	CN1284854C Mosaic type DNA vaccine in use for preventing tuberculosis and immunological therapy
11/15/2006	CN1284602C Ox colostrum active immune globulin micro capsule and its preparation method
11/15/2006	CN1284601C Vaccine composition stable at normal temperature and its preparation
11/14/2006	US7135605 Metal binding proteins and associated methods
11/14/2006	US7135561 Infectious bovine viral diarrhea virus clone
11/14/2006	US7135560 Vectors; cells; drug targets
11/14/2006	US7135555 Mammalian TNF-α convertases
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135457 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
11/14/2006	US7135340 Tetrameric antibody complexes for blocking non-specific labeling of antigens
11/14/2006	US7135333 A CRCA-1 transcript nucleic acid and polynucleotide; host cells; anticarcinogenic agents, gene therapy, antisense agents, vaccines
11/14/2006	US7135303 Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
11/14/2006	US7135301 Detection and treatment of prostate cancer
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods
11/14/2006	US7135280 Assay to determine efficacy of treatment for mycobacterial infection
11/14/2006	US7135278 Method of screening for therapeutics for infectious diseases
11/14/2006	US7135191 Suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals
11/14/2006	US7135188 Methods and compositions for immunotherapy of cancer
11/14/2006	US7135187 System for production of helper dependent adenovirus vectors based on use of endonucleases
11/14/2006	US7135186 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135181 Method for down-regulation of amyloid
11/14/2006	US7135180 Non- boiling foam generation and penetration of preservative agents at temperatures near the phase transfer temperature of the lipid membranes, to preserve bioactive material in a dried foam matrix
11/14/2006	US7135179 Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof
11/14/2006	US7135178 Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	US7135176 VMP-like sequences of pathogenic Borrelia
11/14/2006	US7135175 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/14/2006	US7135174 Antibodies directed to PDGFD and uses thereof
11/14/2006	US7135173 Antiviral activity of Shiga toxin
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2239224C Topiramate immunoassay, as well as analogs and antibodies
11/13/2006	CA2790058A1 Herceptin® adjuvant therapy
11/13/2006	CA2540547A1 Herceptin adjuvant therapy
11/12/2006	CA2606334A1 Methods of using phhla2 to co-stimulate t-cells
11/09/2006	WO2006119291A2 Superantibody synthesis and use in detection, prevention and treatment of disease
11/09/2006	WO2006119115A2 Anti-il-6 antibodies, compositions, methods and uses
11/09/2006	WO2006119095A1 Method for identifying modulators of noah10 useful for treating alzheimer's disease
11/09/2006	WO2006119083A2 Treating gastrointestinal diseases with modulation of retonic acid
11/09/2006	WO2006118916A2 Methods and compositions for polytopic vaccination
11/09/2006	WO2006118622A1 Metering technique for lateral flow assay devices
11/09/2006	WO2006118522A1 Peptides as biomarkers of copd
11/09/2006	WO2006118350A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118196A1 Dpp4 inhibitor and pharmaceutical application thereof
11/09/2006	WO2006118085A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance
11/09/2006	WO2006117910A1 Monoclonal antibody against platelet membrane glycoprotein vi
11/09/2006	WO2006117786A1 Disease therapy using dying or dead cells
11/09/2006	WO2006117782A2 Recombinant antibodies against cd55 and cd59 and uses thereof
11/09/2006	WO2006117586A1 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2
11/09/2006	WO2006117456A1 Preparation of soluble n-protein/truncated p-protein complexes or n-proteins soluble in a virus of the paramyxoviridae family and use thereof in vaccines
11/09/2006	WO2006117241A2 Polypeptide, vaccine and use thereof
11/09/2006	WO2006116873A1 Diagnosis and treatment of endometriosis
11/09/2006	WO2006116867A1 Genemap of the human genes associated with crohn's disease
11/09/2006	WO2006097851A3 Combination vaccines with whole cell pertussis antigen
11/09/2006	WO2006096491A9 Anti-ctla-4 antibody compositions
11/09/2006	WO2006094704A3 Natural ligand of g protein coupled receptor rcc356 and uses thereof
11/09/2006	WO2006094192A3 Humanized l243 antibodies
11/09/2006	WO2006083947A3 Compositions and methods for treating fibrotic disorders
11/09/2006	WO2006073311A3 Treatment of ibd
11/09/2006	WO2006044796A3 Methods and compositions for combinatoral-based production of multivalent recombinant antigens
11/09/2006	WO2005089429A3 Sfec, a sperm flagellar energy carrier protein
11/09/2006	WO2005070026A3 Drug immunoconjugate combination therapy
11/09/2006	WO2005055948A3 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060252921 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
11/09/2006	US20060252829 Formulations and methods for treating amyloidosis
11/09/2006	US20060252724 Method and composition for modulating bone growth
11/09/2006	US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006	US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252132 Influenza hemagglutinin and neuraminidase variants
11/09/2006	US20060252092 Excellent therapeutic efficacy on animals having neurological disorders, such as cerebral apoplexy, brain injury, neurological dysfunctions, Alzheimer's disease and myoclonus
11/09/2006	US20060252052 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060251725 Aggregation of particle sizes
11/09/2006	US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006	US20060251684 Decrease infectivity, morbidity, and/or mortality associated with pathogenic exposure while minimizing microbial resistance, toxicity to the recipient
11/09/2006	US20060251683 Directly injectable formulations which provide enhanced cryoprotection of cell products
11/09/2006	US20060251682 soluble and stable in physiological media; have an additional Cys residue compared with the wild type; utilised for the therapy of grass pollen-induced allergies
11/09/2006	US20060251681 Culturing a eukaryotic host cell transformed with a recombinant DNA construct including a Venezuelan equine encephalitis replicon vector, and at least one DNA fragment encoding any one of the Marburg virus proteins
11/09/2006	US20060251680 Mannose immunogens for HIV-1
11/09/2006	US20060251679 Protein or peptide capable of being fused to ferritin without interfering with the polymeric self-assembly of the resulting fusion protein; metal scavenging
11/09/2006	US20060251678 Useful in the development of stable lines of mammalian, avian and insect cells in which these replicons will persistently replicate; screening for inhibitory compounds of Venezuelan equine encephalitis virus replication and eastern equine encephalitis virus replication
11/09/2006	US20060251677 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
11/09/2006	US20060251676 Hpv-16 and-18 l1 vlp vaccine

1 ... 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 ... 1823